483
G21 USA, Inc.G21 USA, Inc. – FDA 483, Jul 25, 2023
Record Details
An FDA inspection of G21 USA, Inc., an initial importer in New York, revealed significant deficiencies in their quality system. The firm lacked adequate procedures for handling customer complaints, implementing corrective and preventive actions, and documenting personnel training. These issues indicate a need for comprehensive improvements in their operational controls.
View Company Profile
ID · 52fb52de-54e0-4d9b-88b7-b4fa2e5dd63d
Violation Codes1
21 U.S.C. 374(b)
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.